These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 29678675)

  • 1. Towards tailored management of malignant brain tumors with nanotheranostics.
    Aparicio-Blanco J; Torres-Suárez AI
    Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotheranostics, a future remedy of neurological disorders.
    Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
    Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotheranostics for personalized medicine.
    Mura S; Couvreur P
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeted nanomedicines for cancer theranostics.
    Arranja AG; Pathak V; Lammers T; Shi Y
    Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines in the treatment of brain tumors.
    Fisusi FA; Schätzlein AG; Uchegbu IF
    Nanomedicine (Lond); 2018 Mar; 13(6):579-583. PubMed ID: 29376468
    [No Abstract]   [Full Text] [Related]  

  • 8. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging-assisted anticancer nanotherapy.
    Dasgupta A; Biancacci I; Kiessling F; Lammers T
    Theranostics; 2020; 10(3):956-967. PubMed ID: 31938045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme.
    Yao J; Hsu CH; Li Z; Kim TS; Hwang LP; Lin YC; Lin YY
    Curr Pharm Des; 2015; 21(36):5256-66. PubMed ID: 26412354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer nanotheranostics: Strategies, promises and impediments.
    Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
    Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
    Muthu MS; Leong DT; Mei L; Feng SS
    Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
    Muthu MS; Mehata AK; Viswanadh MK
    Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
    [No Abstract]   [Full Text] [Related]  

  • 15. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Potential of Targeted Nanoparticles for Brain Cancer.
    Bhatt A; Gurnany E; Modi A; Gulbake A; Jain A
    Mini Rev Med Chem; 2017; 17(18):1758-1777. PubMed ID: 28969541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotheranostics for Diagnosis and Treatment of Breast Cancer.
    Patel P; Kumar K; Jain VK; Popli H; Yadav AK; Jain K
    Curr Pharm Des; 2023; 29(10):732-747. PubMed ID: 36999427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
    Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
    Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.